- Double Mastectomy May Offer No Survival Benefit to Women With Breast Cancer
- Toxic Lead Found in Cinnamon Product, FDA Says
- Certain Abbott Blood Sugar Monitors May Give Incorrect Readings
- Athletes Can Expect High Ozone, Pollen Counts for Paris Olympics
- Fake Oxycontin Pills Widespread and Potentially Deadly: Report
- Shingles Vaccine Could Lower Dementia Risk
- Your Odds for Accidental Gun Death Rise Greatly in Certain States
- Kids From Poorer Families Less Likely to Survive Cancer
- Tough Workouts Won’t Trigger Cardiac Arrest in Folks With Long QT Syndrome
- At-Home Colon Cancer Test Can Save Lives
Screening May Help Boost Liver Cancer Survival Rates
![](https://ladylively.com/wp-content/uploads/2013/08/diseases12-300x336.jpg)
Increased screening for liver tumors in people with cirrhosis — scarring of the liver — could help boost liver cancer survival rates, according to researchers.
A review of 47 studies that included more than 15,000 patients found the survival rate for those screened with ultrasound scans and blood tests was 51 percent, compared with a 28 percent rate for those who were not screened.
The research team, from the University of Texas Southwestern Medical Center, also found that cirrhosis patients who were screened were more likely to receive treatment for their cancer rather than end-of-life care.
“Curative therapies, such as surgery or a liver transplant, are only available if patients are found to have liver cancer at an early stage. Unfortunately, right now, only a minority of patients’ cancers are found at an early stage,” study author Dr. Amit Singal, medical director of the liver tumor clinic at UT Southwestern’s Harold C. Simmons Cancer Center, said in a medical center news release.
Many cases of liver cancer can be caught early with screening, Singal noted.
“We have a simple test, an abdominal ultrasound, which is painless and easy, but we found that less than 20 percent of at-risk people have the test done, largely due to providers failing to order it,” Singal said.
He hopes the findings, published recently in the online journal PLoS Medicine, will help persuade more cirrhosis patients and their doctors that screening is a good idea.
Liver cancer screening is not currently recommended by the U.S. Preventative Services Task Force, partly because no clinical trial has been conducted to assess its effectiveness, Singal noted.
Liver cancer is the third leading cause of cancer death worldwide. People with cirrhosis are at increased risk, and 3 to 5 percent of them develop liver cancer every year.
More information
The U.S. National Library of Medicine has more about cirrhosis.
Source: HealthDay
Copyright © 2024 HealthDay. All rights reserved.